Buscador de Publicaciones

Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART

Autores: Palacios, R; Perez-Hernandez, IA; Martinez, MA; Mayorga, ML; Gonzalez-Domenech, CM; Omar, M; Olalla, J; Romero, A; Romero, JM; Perez-Camacho, I; Hernandez-Quero, J; Santos, J

Evaluation of the tissue diffusion capacity of antibiotics in lower limb ischaemia

Autores: Lozano-Alonso, S; Linares-Palomino, JP; Vera-Arroyo, B; Bravo-Molina, A; Hernandez-Quero, J; Ros-Die, E

The role of antimicrobial stewardship programs in the control of bacterial resistance

Autores: Pasquau, J; Sadyrbaeva, S; De Jesus, SE; Hidalgo-Tenorio, C

Could specific cell targeting overcome resistance associated with current treatments for African trypanosomiasis?

Autores: Garcia-Salcedo, JA; Unciti-Broceta, JD; Soriano, M

Nanobody conjugated PLGA nanoparticles for active targeting of African Trypanosomiasis

Autores: Arias, JL; Unciti-Broceta, JD; Maceira, J; del Castillo, T; Hernandez-Quero, J; Magez, S; Soriano, M; Garcia-Salcedo, JA

Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study

Autores: Neukam, K; Espinosa, N; Collado, A; Delgado-Fernandez, M; Jimenez-Aguilar, P; Rivero-Juarez, A; Hontanon-Antonana, V; Gomez-Berrocal, A; Ruiz-Morales, J; Merino, D; Carrero, A; Tellez, F; Rios, MJ; Hernandez-Quero, J; de Lagarde-Sebastian, M; Perez-Camacho, I; Vera-Mendez, F; Macias, J; Pineda, JA

The pharmacokinetics of abacavir 600 mg once daily in HIV-1-positive pregnant women

Autores: Schalkwijk, S; Colbers, A; Konopnicki, D; Weizsacker, K; Molto, J; Tenorio, CH; Hawkins, D; Taylor, G; Wood, C; van der Ende, M; Burger, D

< 1 2 … 1.155 1.156 1.157 … 1.504 1.505 >